Trial intelligence / Profile preview

AIMS: Methadone vs Exparel ESPB for Pediatric Scoliosis Pain

NCT05730920Phase 4Completed

Start
Oct 2022
Primary completion
Jul 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of bupivacaine extended release liposome injection in postoperative pain (2 arms). Primary endpoint: Successful Enrollment and Data Collection of 30 Subjects at 2 years. Started Oct 2022; status: completed.

02

Drugs

bupivacaine extended release liposome injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05730920.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05730920.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call